1. Home
  2. NAZ vs PEPG Comparison

NAZ vs PEPG Comparison

Compare NAZ & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Arizona Quality Municipal Income Fund

NAZ

Nuveen Arizona Quality Municipal Income Fund

SELL

Current Price

$10.51

Market Cap

162.0M

Sector

Finance

ML Signal

SELL

Logo PepGen Inc.

PEPG

PepGen Inc.

SELL

Current Price

$2.60

Market Cap

179.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NAZ
PEPG
Founded
1992
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.0M
179.4M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
NAZ
PEPG
Price
$10.51
$2.60
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $10.19
AVG Volume (30 Days)
56.1K
★ 724.1K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
★ 3.69%
N/A
EPS Growth
N/A
★ 25.61
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.18
$1.31
52 Week High
$13.42
$7.80

Technical Indicators

Market Signals
Indicator
NAZ
PEPG
Relative Strength Index (RSI) 29.78 49.70
Support Level $10.18 $1.60
Resistance Level $12.66 $2.62
Average True Range (ATR) 0.26 0.19
MACD 0.02 0.02
Stochastic Oscillator 16.88 75.00

Price Performance

Historical Comparison
NAZ
PEPG

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: